Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Sies H, Stahl W, Sundquist AR
Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically starting at 2.5 mg for 4 weeks, then increasing by 2.5 mg every 4 weeks as tolerated (through intermediate steps of 5 mg, 7.5 mg, 10 mg, 12.5 mg) to a maintenance dose of 5 mg, 10 mg, or 15 mg based on individual response and tolerability
For patients with type 2 diabetes and good commercial coverage, Ozempic is the straightforward choice
Compounded tirzepatide should not be used with other tirzepatide-containing products or any other GLP-1/GIP receptor agonist medicines
.png?w=1280&max-h=720&fit=crop&auto=format)
US$ 23.02
US$ 26.56
US$ 24.09
